22 - CLAP

914. No authors listed. Prevention of haemorrhagic disease of the newborn. Routine vitamin K1 administrationis justified. Prescrire Int. 1998 Aug;7(36):125-7.915. No authors listed.Which vitamin K preparation for the newborn? Drug Ther Bull. 1998 Mar;36(3):17-9.916. Philip RK, Gul R, Dunworth M, Keane N. Ireland lacks consensus on neonatal vitamin K prophylaxis.BMJ. 2001 Nov 3;323(7320):1068.917. Pintadit P, Isarangkura PB, Chalermchandra K, et al.Vitamin K prophylaxis in the neonates by oral routewith different dosages. J Med Assoc Thai. 1989 Jan;72 Suppl 1:125-9.918. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. CochraneDatabase Syst Rev. 2000;(4):CD002776.919. Tonz O, Schubiger G. Neonatal vitamin K prophylaxis and vitamin k deficiency hemorrhages inSwitzerland 1986-1988 Schweiz Med Wochenschr. 1988 Nov 26;118(47):1747-52.920. Uitentuis J. Administration of vitamin K to neonates and infants Ned Tijdschr Geneeskd. 1990 Aug25;134(34):1642-6.921. van Hasselt PM, Houwen RH, van Dijk AT, de Koning TJ. Vitamin K deficiency bleeding in an infantdespite adequate prophylaxis Ned Tijdschr Geneeskd. 2003 Apr 19;147(16):737-40.922. von Kries R, Gobel U. Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn.Lancet. 1994 Feb 5;343(8893):352.923. von Kries R, Gobel U.Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy.Acta Paediatr. 1992 Sep;81(9):655-7.924. von Kries R, Hachmeister A, Gobel U. Oral mixed micellar vitamin K for prevention of late vitamin Kdeficiency bleeding. Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F109-12.925. von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and StandardizationSubcommittee on Perinatal Haemostasis. Thromb Haemost. 1993 Mar 1;69(3):293-5.926. Zipursky A. Prevention of vitamin K deficiency bleeding in newborns. Br J Haematol. 1999Mar;104(3):430-7.Profilaxis ocular927. Bausch LC. Newborn eye prophylaxis—where are we now? Nebr Med J. 1993 Dec;78(12):383-4.928. Bell TA, Grayston JT, Krohn MA, Kronmal RA. Randomized trial of silver nitrate, erythromycin, and noeye prophylaxis for the prevention of conjunctivitis among newborns not at risk for gonococcalophthalmitis. Eye Prophylaxis Study Group. Pediatrics. 1993 Dec;92(6):755-60.929. Bell TA, Sandstrom KI, Gravett MG, et al. Comparison of ophthalmic silver nitrate solution anderythromycin ointment for prevention of natally acquired Chlamydia trachomatis. Sex Transm Dis. 1987Oct-Dec;14(4):195-200.930. Bernstein GA, Davis JP, Katcher ML. Prophylaxis of neonatal conjunctivitis. An analytic review. ClinPediatr (Phila). 1982 Sep;21(9):545-50.931. Bryant BG. Unit dose erythromycin ophthalmic ointment for neonatal ocular prophylaxis. JOGN Nurs.1984 Mar-Apr;13(2):83-7.932. Chen JY. Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycinand no prophylaxis. Pediatr Infect Dis J. 1992 Dec;11(12):1026-30.933. Crede C. Prevention of inflammatory eye disease in the newborn. Bull World Health Organ2001;79(3):264-266.934. Di Bartolomeo S, Mirta DH, Janer M, et al. Incidence of Chlamydia trachomatis and other potentialpathogens in neonatal conjunctivitis. Int J Infect Dis. 2001;5(3):139-43.935. Dunn PM. Dr Carl Crede (1819-1892) and the prevention of ophthalmia neonatorum. Arch Dis ChildFetal Neonatal Ed. 2000 Sep;83(2):F158-9. 123MANUAL CLÍNICO AIEPI NEONATAL